# Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.

> **NCT07658378** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Helwan University** · enrollment: 100 (estimated)

## Conditions studied

- Surgical Site Infection (SSI)

## Interventions

- **DRUG:** Cefazolin 2 g Infusion
- **DRUG:** Cefazolin 2 GM Injection

## Key facts

- **NCT ID:** NCT07658378
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658378, "Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*